17-18130805-A-T

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_016239.4(MYO15A):​c.4033A>T​(p.Ile1345Leu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00313 in 1,605,052 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0018 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0033 ( 12 hom. )

Consequence

MYO15A
NM_016239.4 missense, splice_region

Scores

8
10
Splicing: ADA: 0.01628
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:5

Conservation

PhyloP100: 2.39
Variant links:
Genes affected
MYO15A (HGNC:7594): (myosin XVA) This gene encodes an unconventional myosin. This protein differs from other myosins in that it has a long N-terminal extension preceding the conserved motor domain. Studies in mice suggest that this protein is necessary for actin organization in the hair cells of the cochlea. Mutations in this gene have been associated with profound, congenital, neurosensory, nonsyndromal deafness. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Read-through transcripts containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternatively spliced transcript variants have been described, but their full length sequences have not been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01732254).
BP6
Variant 17-18130805-A-T is Benign according to our data. Variant chr17-18130805-A-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 198880.We mark this variant Likely_benign, oryginal submissions are: {Benign=2, Uncertain_significance=2, Likely_benign=2}. Variant chr17-18130805-A-T is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAdExome4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYO15ANM_016239.4 linkuse as main transcriptc.4033A>T p.Ile1345Leu missense_variant, splice_region_variant 8/66 ENST00000647165.2 NP_057323.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYO15AENST00000647165.2 linkuse as main transcriptc.4033A>T p.Ile1345Leu missense_variant, splice_region_variant 8/66 NM_016239.4 ENSP00000495481 P1Q9UKN7-1

Frequencies

GnomAD3 genomes
AF:
0.00182
AC:
264
AN:
145434
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000655
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000412
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000512
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00341
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00153
AC:
377
AN:
246486
Hom.:
3
AF XY:
0.00159
AC XY:
213
AN XY:
133988
show subpopulations
Gnomad AFR exome
AF:
0.000582
Gnomad AMR exome
AF:
0.000319
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000378
Gnomad NFE exome
AF:
0.00311
Gnomad OTH exome
AF:
0.000331
GnomAD4 exome
AF:
0.00326
AC:
4761
AN:
1459506
Hom.:
12
Cov.:
32
AF XY:
0.00313
AC XY:
2275
AN XY:
726164
show subpopulations
Gnomad4 AFR exome
AF:
0.000540
Gnomad4 AMR exome
AF:
0.000314
Gnomad4 ASJ exome
AF:
0.000230
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000604
Gnomad4 NFE exome
AF:
0.00413
Gnomad4 OTH exome
AF:
0.00169
GnomAD4 genome
AF:
0.00181
AC:
264
AN:
145546
Hom.:
0
Cov.:
30
AF XY:
0.00171
AC XY:
121
AN XY:
70726
show subpopulations
Gnomad4 AFR
AF:
0.000653
Gnomad4 AMR
AF:
0.000412
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000512
Gnomad4 NFE
AF:
0.00341
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.00191
Hom.:
0
Bravo
AF:
0.00174
ESP6500AA
AF:
0.000487
AC:
2
ESP6500EA
AF:
0.00406
AC:
34
ExAC
AF:
0.00150
AC:
182
Asia WGS
AF:
0.000289
AC:
1
AN:
3476

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)May 12, 2015- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMay 01, 2022MYO15A: PP3, BS2 -
Benign, criteria provided, single submitterclinical testingGeneDxJan 21, 2019- -
Autosomal recessive nonsyndromic hearing loss 3 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 30, 2012Ile1345Leu in Exon 08 of MYO15A: This variant is not expected to have clinical s ignificance because it has been identified in 0.4% (27/6778) of European America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS). -
MYO15A-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 21, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.060
CADD
Uncertain
25
DANN
Benign
0.97
DEOGEN2
Benign
0.20
T;T
Eigen
Uncertain
0.28
Eigen_PC
Benign
0.18
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.28
.;T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.017
T;T
MetaSVM
Uncertain
0.36
D
MutationAssessor
Benign
1.2
L;L
MutationTaster
Benign
1.0
D
PROVEAN
Benign
-0.71
N;.
REVEL
Uncertain
0.55
Sift
Uncertain
0.019
D;.
Sift4G
Uncertain
0.0090
D;.
Vest4
0.46
MutPred
0.41
Gain of helix (P = 0.0854);Gain of helix (P = 0.0854);
MVP
0.84
ClinPred
0.023
T
GERP RS
2.7
Varity_R
0.19
gMVP
0.34

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.016
dbscSNV1_RF
Benign
0.13
SpliceAI score (max)
0.20
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.20
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201234482; hg19: chr17-18034119; COSMIC: COSV52755181; API